Arbutus Biopharma Corp Accretion (Amortization) of Discounts and Premiums, Investments
Arbutus Biopharma Corp (ABUS) reported Accretion (Amortization) of Discounts and Premiums, Investments of $675.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments · last filed 2026-08-12
- Arbutus Biopharma Corp accretion (amortization) of discounts and premiums, investments for the quarter ending 2026-06-30 was $321.00K, a 51.95% decline year-over-year.
- Arbutus Biopharma Corp accretion (amortization) of discounts and premiums, investments for the quarter ending 2026-03-31 was $354.00K, a 50.70% decline year-over-year.
- Arbutus Biopharma Corp accretion (amortization) of discounts and premiums, investments for the quarter ending 2025-12-31 was $422.00K, a 54.28% decline year-over-year.
- Arbutus Biopharma Corp accretion (amortization) of discounts and premiums, investments for the quarter ending 2025-09-30 was $541.00K, a 44.96% decline year-over-year.
- Arbutus Biopharma Corp accretion (amortization) of discounts and premiums, investments for fiscal 2025 was $2.35M, a 25.07% decline from fiscal 2024.
- Arbutus Biopharma Corp accretion (amortization) of discounts and premiums, investments for fiscal 2024 was $3.13M, a 42.76% increase from fiscal 2023.
- Arbutus Biopharma Corp accretion (amortization) of discounts and premiums, investments for fiscal 2023 was $2.20M, a 3966.67% increase from fiscal 2022.
- Arbutus Biopharma Corp accretion (amortization) of discounts and premiums, investments for fiscal 2022 was $54.00K.
| Period end | Accretion (Amortization) of Discounts and Premiums, Investments 3 month | Accretion (Amortization) of Discounts and Premiums, Investments 6 month | Accretion (Amortization) of Discounts and Premiums, Investments 9 month | Accretion (Amortization) of Discounts and Premiums, Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $675.00K 10-Q · filed 2026-08-12 | $1.10M derived: sum of 3 quarters · filed 2026-08-12 | $1.64M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $354.00K 10-Q · filed 2026-05-13 | $776.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.32M derived: sum of 3 quarters · filed 2026-05-13 | $1.99M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $963.00K derived: sum of 2 quarters · filed 2026-03-23 | $1.63M derived: sum of 3 quarters · filed 2026-08-12 | $2.35M 10-K · filed 2026-03-23 |
| 2025-09-30 | $541.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.21M derived: sum of 2 quarters · filed 2026-08-12 | $1.93M 10-Q · filed 2025-11-13 | $2.85M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $668.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.39M 10-Q · filed 2026-08-12 | $2.31M derived: sum of 3 quarters · filed 2026-08-12 | $3.29M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $718.00K 10-Q · filed 2026-05-13 | $1.64M derived: sum of 2 quarters · filed 2026-05-13 | $2.62M derived: sum of 3 quarters · filed 2026-05-13 | $3.30M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $923.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.91M derived: sum of 2 quarters · filed 2026-03-23 | $2.58M derived: sum of 3 quarters · filed 2026-03-23 | $3.13M 10-K · filed 2026-03-23 |
| 2024-09-30 | $983.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.66M derived: sum of 2 quarters · filed 2025-11-13 | $2.21M 10-Q · filed 2025-11-13 | $2.83M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $676.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.23M 10-Q · filed 2025-08-06 | $1.85M derived: sum of 3 quarters · filed 2025-08-06 | $2.51M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $553.00K 10-Q · filed 2025-05-14 | $1.17M derived: sum of 2 quarters · filed 2025-05-14 | $1.83M derived: sum of 3 quarters · filed 2025-05-14 | $2.36M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $619.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.28M derived: sum of 2 quarters · filed 2025-03-27 | $1.81M derived: sum of 3 quarters · filed 2025-03-27 | $2.20M 10-K · filed 2025-03-27 |
| 2023-09-30 | $658.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.19M derived: sum of 2 quarters · filed 2024-11-06 | $1.58M 10-Q · filed 2024-11-06 | $1.80M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $919.00K 10-Q · filed 2024-08-08 | $1.14M derived: sum of 3 quarters · filed 2024-08-08 | $1.22M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $385.00K 10-Q · filed 2024-05-02 | $609.00K derived: sum of 2 quarters · filed 2024-05-02 | $690.00K derived: sum of 3 quarters · filed 2024-05-02 | $607.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $305.00K derived: sum of 2 quarters · filed 2024-03-05 | $222.00K derived: sum of 3 quarters · filed 2024-03-05 | $54.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$2.00K derived: sum of 2 quarters · filed 2023-11-07 | -$170.00K 10-Q · filed 2023-11-07 | -$416.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$251.00K 10-Q · filed 2023-08-03 | -$497.00K derived: sum of 3 quarters · filed 2023-08-03 | -$797.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$168.00K 10-Q · filed 2023-05-04 | -$414.00K derived: sum of 2 quarters · filed 2023-05-04 | -$714.00K derived: sum of 3 quarters · filed 2023-05-04 | -$1.01M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$546.00K derived: sum of 2 quarters · filed 2023-03-02 | -$840.00K derived: sum of 3 quarters · filed 2023-03-02 | -$999.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$594.00K derived: sum of 2 quarters · filed 2022-11-09 | -$753.00K 10-Q · filed 2022-11-09 | -$892.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$453.00K 10-Q · filed 2022-08-04 | -$592.00K derived: sum of 3 quarters · filed 2022-08-04 | -$623.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$159.00K 10-Q · filed 2022-05-05 | -$298.00K derived: sum of 2 quarters · filed 2022-05-05 | -$329.00K derived: sum of 3 quarters · filed 2022-05-05 | -$371.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$170.00K derived: sum of 2 quarters · filed 2022-03-03 | -$212.00K derived: sum of 3 quarters · filed 2022-03-03 | -$210.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$73.00K derived: sum of 2 quarters · filed 2021-11-04 | -$71.00K 10-Q · filed 2021-11-04 | $204.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$40.00K 10-Q · filed 2021-08-05 | $235.00K derived: sum of 3 quarters · filed 2021-08-05 | $235.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-05 | $277.00K derived: sum of 2 quarters · filed 2021-05-05 | $277.00K derived: sum of 3 quarters · filed 2021-05-05 | $277.00K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $275.00K derived: sum of 2 quarters · filed 2021-03-04 | $275.00K derived: sum of 3 quarters · filed 2021-03-04 | $275.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $0.00 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |